Navacilla, Daisy Mae C.

HRN: 09-37-59  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/16/2022
CEFUROXIME 500MG (TAB)
05/16/2022
05/23/2022
PO
500mg
Bid
Abrasions
Waiting Final Action 
05/16/2022
MUPIROCIN 2%, 15G (TUBE)
05/16/2022
05/23/2022
TOPICAL
1g
Bid
Abrasions
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: